EGFR and cancer: Growing evidence suggests that CSCs play a pivotal role in inherent or acquired resistance to γ-radiation and targeted cancer drugs, such as epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs)1–3.